“It’s now our variant,” Simón informed journalists throughout Monday’s state press convention, in reference to the truth that the pressure that was first detected within the UK is now probably the most predominant of the Covid variants in Spain.
In 11 Spanish areas the B.1.1.7 variant is liable for greater than 70 p.c of latest circumstances and in 5 others it accounts for greater than 90 p.c of latest infections (Asturias, Galicia, Cantabria, Navarre and Catalonia).
Simón, who in January had forecast that the impression of the so-called British pressure can be marginal, has now mentioned that its enlargement throughout the Spanish inhabitants “could possibly be benefiting us” as “it’s leaving no room” for the South African and Brazilian variants to take maintain.
“The Brazilian and the South African strains are those that curiosity us and fear us most,” Simón, informed journalists on Monday.
The pinnacle of Spain’s Centre for Well being Alerts and Emergency Coordination added that it wasn’t mandatory to provide the fast unfold of the UK coronavirus variant “an excessive amount of significance” and that as an alternative it was preferable to “be very cautious” with the opposite two variants, which have to this point had a restricted impression in Spain however are reported to be extra aggressive and more durable to cease.
AstraZeneca vaccine for over 65s “quickly”
“It’s doable that the AstraZeneca vaccine in Spain could also be supplied quickly to individuals over 65 years of age, ” Simón mentioned at a press convention.
Spain’s well being ministry introduced final Tuesday that it was extending the roll-out of the AstraZeneca Covid-19 vaccine to the over-65s, after current scientific reassurances about its security.
However well being authorities are nonetheless vaccinating Spain’s over 80s, having inoculated 70 p.c of this age group by the beginning of April.
“Each time we now have extra strong proof that in individuals over 65 the AstraZeneca vaccine may have the impact that we wish it to have,” Simón acknowledged.
On March tenth the World Well being Organisation (WHO) really useful the AstraZeneca vaccine for individuals over 65s after a number of international locations had set that age restrict at 55, together with Spain.
Spain was additionally amongst a lot of European Union international locations that suspended use of the AstraZeneca vaccine earlier this month after reviews of blood clots in a really small variety of individuals.
However they resumed its use on March twenty fourth after each the World Well being Organisation and the European Medicines Company gave the vaccine a clear invoice of well being.
A current research in famend medical journal The Lancet which researched whether or not the AstraZeneca vaccine labored properly in defending in opposition to the B.1.1.7 variant, often known as the British pressure, discovered that it helped shield in opposition to symptomatic sickness brought on by this novel variant.
READ ALSO: In Europe questions linger over doable AstraZeneca jab side-effects